CNS Pharmaceuticals Announces Pricing Of $6.0 Million Public Offering

Published on November 30, 2022 07:03 PM PST

Nov 30 (Reuters) - Cns Pharmaceuticals Inc:

* CNS PHARMACEUTICALS ANNOUNCES PRICING OF $6.0 MILLION PUBLIC OFFERING AT A PREMIUM TO THE MARKET CLOSING PRICE

* PRICING OF A PUBLIC OFFERING OF 1.9 MILLION SHARES OF COMMON STOCK AND WARRANTS AT A COMBINED PRICE OF $3.175 PER SHARE Source text for Eikon: Further company coverage:

Reuters

Reuters -
94188 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.